Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive

Jadhav, Sanjay; Nalawade, Harshada

dc.contributor.author	Jadhav, Sanjay
dc.contributor.author	Nalawade, Harshada
dc.date.accessioned	2021-10-14T09:11:42Z
dc.date.available	2021-10-14T09:11:42Z
dc.date.issued	2021-09
dc.identifier.citation	Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive	en_US
dc.identifier.issn	2581-9879
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/9975
dc.description.abstract	Actually IP waiver was initiated with a proposal by India and South Africa at WTO at last year October 8.It was for a waiver on all covid-19 invention including testing as well as diagnostics under the conditions of trips agreement. Now it will take to remove intellectual property rights for vaccines should result in universal response to the current pandemic situation and way to tackle coming new variants of covid-19.Patent waiver on vaccines may create a barrier to share information for others for production of vaccines.	en_US
dc.language.iso	en	en_US
dc.publisher	Kesari Mahratta Trust	en_US
dc.subject	COVID-19	en_US
dc.subject	Corona virus Pandemic	en_US
dc.subject	Patent waiver	en_US
dc.title	Waiver of patent rights on Covid-19 vaccines, in near term, may be more symbolic than substantive	en_US
dc.type	Article	en_US